Stock Quote

 
Research Another Stock: Symbol Look-up
Isolagen files for Chapter 11 protection
Tuesday, 16 Jun 2009 12:27am EDT 
Patents could mean cash for bankrupt biotechs
Wednesday, 18 Mar 2009 01:29pm EDT 
Isolagen says CEO resigned, names successor
Tuesday, 8 Jan 2008 08:50am EST 
FDA Calendar Updates: AspenBio, Acrux, Isolagen, Human Genome Sciences
Monday, 16 Mar 2009 06:05am EDT(SeekingAlpha) 
Trading FDA Decisions: 14 Candidates
Thursday, 12 Mar 2009 03:07am EDT(SeekingAlpha) 
With Funding Ban Lifted, Stem Cell Index Soars
Tuesday, 10 Mar 2009 03:33pm EDT(SeekingAlpha) 
Expecting Post-Stimulus Catalyst for Stem Cell Research Companies
Monday, 16 Feb 2009 08:06am EST(SeekingAlpha) 
32 Stem Cell Companies to Watch
Wednesday, 4 Feb 2009 04:57am EST(SeekingAlpha) 
 

Profile

Isolagen, Inc.(Isolagen) is an aesthetic and therapeutic development stage company focused on developing skin and tissue rejuvenation products. It operates in two segments: Isolagen Therapy and Agera. The Isolagen Therapy segment specializes in the development and commercialization of autologous... Full Description

Company Address

Isolagen, Inc.
405 Eagleview Boulevard
Exton   PA   19341
P: +1484.7136000
F: +1484.7136001

Analyst Research

Performance of Key Competitors

Company Price Change
Genzyme Corporation $50.41 +0.36
Integra LifeSciences Holdings Corp. $32.50 +0.51
Johnson & Johnson $62.60 +0.29
  ILE.A Industry
P/E(TTM) -- 12.80
P/S(TTM) 0.00 29.90
ROI(TTM) -- 2.35
ROE(TTM) -- 3.59
No consensus estimates data available.
Total Revenue $0.25M
Net Income $-2.97M
EPS $-0.08